Haemostatic factors in the ASTAMI study, with special reference to left ventricular thrombus.
- Prosjektnummer
- 2009034
- Ansvarlig person
- Svein Solheim
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Cardiovascular
- Forskningsaktivitet
- 2. Aetiology
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy.
Thromb J 2013;11(1):1. Epub 2013 jan 11
PMID: 23311309
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
Thromb Res 2012 Nov;130(5):765-8. Epub 2011 des 20
PMID: 22192151
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy.
Am J Cardiol 2010 Nov;106(9):1197-200. Epub 2010 sep 9
PMID: 21029812
The Influence of Intracoronary Injection of Mononuclear Bone Marrow Cells on Prothrombotic Markers in Patients with AMI
European Atherosclerosis Society Congress 2011, Gothenburg, Sweden (poster)
Prothrombotic markers in patients with AMI and left ventricular thrombus formation treated with dual antiplatelet therapy
European Society of Cardiology 2011, Paris, France (oral presentation)
The Influence of Intracoronary Injection of Mononuclear Bone Marrow Cells on Prothrombotic Markers in Patients with Acute Myocar
8th Annual CHFR (Center for Heart Failure Research) Symposium on September 30, 2010
Prothrombotic Markers in Patients with Acute Myocardial Infarction and Left Ventricular Thrombus Formation Treated with Dual Ant
8th Annual CHFR (Center for Heart Failure Research) Symposium on September 30, 2010
- Kolbjørn Forfang Prosjektdeltaker
- Svend Aakhus Prosjektdeltaker
- Ketil Lunde Prosjektdeltaker
- Harald Arnesen Prosjektdeltaker
- Svein Solheim Prosjektleder
- Ingebjørg Seljeflot Forskningsgruppeleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport